http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25051834

Outgoing Links

Predicate Object
contentType Published Erratum
issn 2352-3964
pageRange 102629-
publicationName EBioMedicine
startingPage 102629
bibliographicCitation Zhang T, Li J, Ma X, Yang Y, Sun W, Jin W, Wang L, He Y, Yang F, Yi Z, Hua Y, Liu M, Chen Y, Cai Z. Corrigendum to 'Inhibition of HDACs-EphA2 signaling axis with WW437 demonstrates promising preclinical antitumor activity in breast cancer' [EBioMedicine 31 (2018) 276-286]. EBioMedicine. 2020 Feb;52():102629. PMID: 31972471; PMCID: PMC6974763.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5c4f97e744593c04cb7f2e6e1ccde7f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_effbcf9bf7b0e18a98eae975bf888bf6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a588fb9e68920c9161521e0dd108dd82
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f0f7053ac82fdd8a26f3f44e136c63b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d08e488caedbdff8529828bcb5dd1fbe
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6d0a05cc237f67cde04146d2267669b1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5f5e17fb2a8158858d83ac981cb62af
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12dd684bcb5180feb92d6a34c3971302
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9bf8476d5b92f32235bdfc6974023f04
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_095e1e1d9200ba62b8d14434b9059104
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_881a0dbb2dead187da6521cda273f049
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_618cb4f3b3947af316b3bdc7aa7b320b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_037a73a0748cf0c3f041b82224932bc9
date 202002
identifier https://pubmed.ncbi.nlm.nih.gov/PMC6974763
https://pubmed.ncbi.nlm.nih.gov/31972471
https://doi.org/10.1016/j.ebiom.2020.102629
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/43277
https://portal.issn.org/resource/ISSN/2352-3964
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Corrigendum to ‘Inhibition of HDACs-EphA2 signaling axis with WW437 demonstrates promising preclinical antitumor activity in breast cancer’ [EBioMedicine 31 (2018) 276–286]
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4b314c92a79e626165622f7b6869f840

Total number of triples: 32.